 | • レポートコード：D005-05165 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：化学・材料 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ジヒドロアルテミシニンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ジヒドロアルテミシニンの種類別市場規模（医薬品用、工業用）、用途別市場規模（マラリア治療、科学研究、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sanofi、Botanical Extracts EPZ Ltd、Guilin Pharmaceutical、KPC Pharmaceuticals、Novanat Bioresource、Guangxi Xiancaotang Pharmaceutical、Shanghai Natural Bio-engineering Co、Kerui Nanhai Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・ジヒドロアルテミシニンの北米市場（アメリカ、カナダ、メキシコ） ・ジヒドロアルテミシニンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ジヒドロアルテミシニンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ジヒドロアルテミシニンの南米市場（ブラジル、アルゼンチン） ・ジヒドロアルテミシニンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：医薬品用、工業用 ・用途別分析：マラリア治療、科学研究、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Dihydroartemisinin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Dihydroartemisinin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Dihydroartemisinin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Dihydroartemisinin market has been segmented into
Pharmaceutical Grade
Industrial Grade
By Application, Dihydroartemisinin has been segmented into:
Malaria Treatment
Scientific Research
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Dihydroartemisinin market presented in the report. This section sheds light on the sales growth of different regional and country-level Dihydroartemisinin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Dihydroartemisinin market.
The report offers in-depth assessment of the growth and other aspects of the Dihydroartemisinin market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Dihydroartemisinin Market Share Analysis
Dihydroartemisinin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Dihydroartemisinin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Dihydroartemisinin sales, revenue and market share for each player covered in this report.
The major players covered in Dihydroartemisinin are:
Sanofi
Botanical Extracts EPZ Ltd
Guilin Pharmaceutical
KPC Pharmaceuticals
Novanat Bioresource
Guangxi Xiancaotang Pharmaceutical
Shanghai Natural Bio-engineering Co
Kerui Nanhai Pharmaceutical
Among other players domestic and global, Dihydroartemisinin market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dihydroartemisinin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dihydroartemisinin, with price, sales, revenue and global market share of Dihydroartemisinin in 2018 and 2019.
Chapter 3, the Dihydroartemisinin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dihydroartemisinin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Dihydroartemisinin market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Dihydroartemisinin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Dihydroartemisinin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dihydroartemisinin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Pharmaceutical Grade
1.2.3 Industrial Grade
1.3 Market Analysis by Application
1.3.1 Overview: Global Dihydroartemisinin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Malaria Treatment
1.3.3 Scientific Research
1.3.4 Others
1.4 Overview of Global Dihydroartemisinin Market
1.4.1 Global Dihydroartemisinin Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Dihydroartemisinin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Botanical Extracts EPZ Ltd
2.2.1 Botanical Extracts EPZ Ltd Details
2.2.2 Botanical Extracts EPZ Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Botanical Extracts EPZ Ltd SWOT Analysis
2.2.4 Botanical Extracts EPZ Ltd Product and Services
2.2.5 Botanical Extracts EPZ Ltd Dihydroartemisinin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Guilin Pharmaceutical
2.3.1 Guilin Pharmaceutical Details
2.3.2 Guilin Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Guilin Pharmaceutical SWOT Analysis
2.3.4 Guilin Pharmaceutical Product and Services
2.3.5 Guilin Pharmaceutical Dihydroartemisinin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 KPC Pharmaceuticals
2.4.1 KPC Pharmaceuticals Details
2.4.2 KPC Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 KPC Pharmaceuticals SWOT Analysis
2.4.4 KPC Pharmaceuticals Product and Services
2.4.5 KPC Pharmaceuticals Dihydroartemisinin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novanat Bioresource
2.5.1 Novanat Bioresource Details
2.5.2 Novanat Bioresource Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novanat Bioresource SWOT Analysis
2.5.4 Novanat Bioresource Product and Services
2.5.5 Novanat Bioresource Dihydroartemisinin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Guangxi Xiancaotang Pharmaceutical
2.6.1 Guangxi Xiancaotang Pharmaceutical Details
2.6.2 Guangxi Xiancaotang Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Guangxi Xiancaotang Pharmaceutical SWOT Analysis
2.6.4 Guangxi Xiancaotang Pharmaceutical Product and Services
2.6.5 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Shanghai Natural Bio-engineering Co
2.7.1 Shanghai Natural Bio-engineering Co Details
2.7.2 Shanghai Natural Bio-engineering Co Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Shanghai Natural Bio-engineering Co SWOT Analysis
2.7.4 Shanghai Natural Bio-engineering Co Product and Services
2.7.5 Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Kerui Nanhai Pharmaceutical
2.8.1 Kerui Nanhai Pharmaceutical Details
2.8.2 Kerui Nanhai Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Kerui Nanhai Pharmaceutical SWOT Analysis
2.8.4 Kerui Nanhai Pharmaceutical Product and Services
2.8.5 Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Dihydroartemisinin Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Dihydroartemisinin Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Dihydroartemisinin Manufacturer Market Share in 2019
3.3.2 Top 6 Dihydroartemisinin Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Dihydroartemisinin Sales, Revenue and Market Share by Regions
4.1.1 Global Dihydroartemisinin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Dihydroartemisinin Revenue and Market Share by Regions (2015-2020)
4.2 North America Dihydroartemisinin Sales and Growth Rate (2015-2020)
4.3 Europe Dihydroartemisinin Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Dihydroartemisinin Sales and Growth Rate (2015-2020)
4.5 South America Dihydroartemisinin Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Dihydroartemisinin Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Dihydroartemisinin Sales, Revenue and Market Share by Country
5.1.1 North America Dihydroartemisinin Sales and Market Share by Country (2015-2020)
5.1.2 North America Dihydroartemisinin Revenue and Market Share by Country (2015-2020)
5.2 United States Dihydroartemisinin Sales and Growth Rate (2015-2020)
5.3 Canada Dihydroartemisinin Sales and Growth Rate (2015-2020)
5.4 Mexico Dihydroartemisinin Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Dihydroartemisinin Sales, Revenue and Market Share by Country
6.1.1 Europe Dihydroartemisinin Sales and Market Share by Country (2015-2020)
6.1.2 Europe Dihydroartemisinin Revenue and Market Share by Country (2015-2020)
6.2 Germany Dihydroartemisinin Sales and Growth Rate (2015-2020)
6.3 UK Dihydroartemisinin Sales and Growth Rate (2015-2020)
6.4 France Dihydroartemisinin Sales and Growth Rate (2015-2020)
6.5 Russia Dihydroartemisinin Sales and Growth Rate (2015-2020)
6.6 Italy Dihydroartemisinin Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Dihydroartemisinin Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Dihydroartemisinin Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Dihydroartemisinin Revenue and Market Share by Regions (2015-2020)
7.2 China Dihydroartemisinin Sales and Growth Rate (2015-2020)
7.3 Japan Dihydroartemisinin Sales and Growth Rate (2015-2020)
7.4 Korea Dihydroartemisinin Sales and Growth Rate (2015-2020)
7.5 India Dihydroartemisinin Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Dihydroartemisinin Sales and Growth Rate (2015-2020)
7.7 Australia Dihydroartemisinin Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Dihydroartemisinin Sales, Revenue and Market Share by Country
8.1.1 South America Dihydroartemisinin Sales and Market Share by Country (2015-2020)
8.1.2 South America Dihydroartemisinin Revenue and Market Share by Country (2015-2020)
8.2 Brazil Dihydroartemisinin Sales and Growth Rate (2015-2020)
8.3 Argentina Dihydroartemisinin Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Dihydroartemisinin Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Dihydroartemisinin Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Dihydroartemisinin Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Dihydroartemisinin Sales and Growth Rate (2015-2020)
9.3 Turkey Dihydroartemisinin Sales and Growth Rate (2015-2020)
9.4 Egypt Dihydroartemisinin Sales and Growth Rate (2015-2020)
9.5 South Africa Dihydroartemisinin Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Dihydroartemisinin Sales and Market Share by Type (2015-2020)
10.2 Global Dihydroartemisinin Revenue and Market Share by Type (2015-2020)
10.3 Global Dihydroartemisinin Price by Type (2015-2020)
11 Global Dihydroartemisinin Market Segment by Application
11.1 Global Dihydroartemisinin Sales Market Share by Application (2015-2020)
11.2 Global Dihydroartemisinin Revenue Market Share by Application (2015-2020)
11.3 Global Dihydroartemisinin Price by Application (2015-2020)
12 Market Forecast
12.1 Global Dihydroartemisinin Sales, Revenue and Growth Rate (2021-2025)
12.2 Dihydroartemisinin Market Forecast by Regions (2021-2025)
12.2.1 North America Dihydroartemisinin Market Forecast (2021-2025)
12.2.2 Europe Dihydroartemisinin Market Forecast (2021-2025)
12.2.3 Asia-Pacific Dihydroartemisinin Market Forecast (2021-2025)
12.2.4 South America Dihydroartemisinin Market Forecast (2021-2025)
12.2.5 Middle East & Africa Dihydroartemisinin Market Forecast (2021-2025)
12.3 Dihydroartemisinin Market Forecast by Type (2021-2025)
12.3.1 Global Dihydroartemisinin Sales Forecast by Type (2021-2025)
12.3.2 Global Dihydroartemisinin Market Share Forecast by Type (2021-2025)
12.4 Dihydroartemisinin Market Forecast by Application (2021-2025)
12.4.1 Global Dihydroartemisinin Sales Forecast by Application (2021-2025)
12.4.2 Global Dihydroartemisinin Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Dihydroartemisinin Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Dihydroartemisinin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Dihydroartemisinin Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Dihydroartemisinin Major Business
Table 9. Sanofi Dihydroartemisinin Total Revenue (USD Million) (2018-2019)
Table 10. Sanofi SWOT Analysis
Table 11. Sanofi Dihydroartemisinin Product and Services
Table 12. Sanofi Dihydroartemisinin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Botanical Extracts EPZ Ltd Basic Information, Manufacturing Base and Competitors
Table 14. Botanical Extracts EPZ Ltd Dihydroartemisinin Major Business
Table 15. Botanical Extracts EPZ Ltd Dihydroartemisinin Total Revenue (USD Million) (2018-2019)
Table 16. Botanical Extracts EPZ Ltd SWOT Analysis
Table 17. Botanical Extracts EPZ Ltd Dihydroartemisinin Product and Services
Table 18. Botanical Extracts EPZ Ltd Dihydroartemisinin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Guilin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Guilin Pharmaceutical Dihydroartemisinin Major Business
Table 21. Guilin Pharmaceutical Dihydroartemisinin Total Revenue (USD Million) (2018-2019)
Table 22. Guilin Pharmaceutical SWOT Analysis
Table 23. Guilin Pharmaceutical Dihydroartemisinin Product and Services
Table 24. Guilin Pharmaceutical Dihydroartemisinin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. KPC Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 26. KPC Pharmaceuticals Dihydroartemisinin Major Business
Table 27. KPC Pharmaceuticals Dihydroartemisinin Total Revenue (USD Million) (2018-2019)
Table 28. KPC Pharmaceuticals SWOT Analysis
Table 29. KPC Pharmaceuticals Dihydroartemisinin Product and Services
Table 30. KPC Pharmaceuticals Dihydroartemisinin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Novanat Bioresource Basic Information, Manufacturing Base and Competitors
Table 32. Novanat Bioresource Dihydroartemisinin Major Business
Table 33. Novanat Bioresource Dihydroartemisinin Total Revenue (USD Million) (2018-2019)
Table 34. Novanat Bioresource SWOT Analysis
Table 35. Novanat Bioresource Dihydroartemisinin Product and Services
Table 36. Novanat Bioresource Dihydroartemisinin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Guangxi Xiancaotang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 38. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Major Business
Table 39. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Total Revenue (USD Million) (2018-2019)
Table 40. Guangxi Xiancaotang Pharmaceutical SWOT Analysis
Table 41. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Product and Services
Table 42. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Shanghai Natural Bio-engineering Co Basic Information, Manufacturing Base and Competitors
Table 44. Shanghai Natural Bio-engineering Co Dihydroartemisinin Major Business
Table 45. Shanghai Natural Bio-engineering Co Dihydroartemisinin Total Revenue (USD Million) (2018-2019)
Table 46. Shanghai Natural Bio-engineering Co SWOT Analysis
Table 47. Shanghai Natural Bio-engineering Co Dihydroartemisinin Product and Services
Table 48. Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Kerui Nanhai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 50. Kerui Nanhai Pharmaceutical Dihydroartemisinin Major Business
Table 51. Kerui Nanhai Pharmaceutical Dihydroartemisinin Total Revenue (USD Million) (2018-2019)
Table 52. Kerui Nanhai Pharmaceutical SWOT Analysis
Table 53. Kerui Nanhai Pharmaceutical Dihydroartemisinin Product and Services
Table 54. Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global Dihydroartemisinin Sales by Manufacturer (2018-2019) (K MT)
Table 56. Global Dihydroartemisinin Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global Dihydroartemisinin Sales by Regions (2015-2020) (K MT)
Table 58. Global Dihydroartemisinin Sales Market Share by Regions (2015-2020)
Table 59. Global Dihydroartemisinin Revenue by Regions (2015-2020) (USD Million)
Table 60. North America Dihydroartemisinin Sales by Countries (2015-2020) (K MT)
Table 61. North America Dihydroartemisinin Sales Market Share by Countries (2015-2020)
Table 62. North America Dihydroartemisinin Revenue by Countries (2015-2020) (USD Million)
Table 63. North America Dihydroartemisinin Revenue Market Share by Countries (2015-2020)
Table 64. Europe Dihydroartemisinin Sales by Countries (2015-2020) (K MT)
Table 65. Europe Dihydroartemisinin Sales Market Share by Countries (2015-2020)
Table 66. Europe Dihydroartemisinin Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific Dihydroartemisinin Sales by Regions (2015-2020) (K MT)
Table 68. Asia-Pacific Dihydroartemisinin Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific Dihydroartemisinin Revenue by Regions (2015-2020) (USD Million)
Table 70. South America Dihydroartemisinin Sales by Countries (2015-2020) (K MT)
Table 71. South America Dihydroartemisinin Sales Market Share by Countries (2015-2020)
Table 72. South America Dihydroartemisinin Revenue by Countries (2015-2020) (USD Million)
Table 73. South America Dihydroartemisinin Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa Dihydroartemisinin Sales by Countries (2015-2020) (K MT)
Table 75. Middle East & Africa Dihydroartemisinin Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa Dihydroartemisinin Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa Dihydroartemisinin Revenue Market Share by Countries (2015-2020)
Table 78. Global Dihydroartemisinin Sales by Type (2015-2020) (K MT)
Table 79. Global Dihydroartemisinin Sales Share by Type (2015-2020)
Table 80. Global Dihydroartemisinin Revenue by Type (2015-2020) (USD Million)
Table 81. Global Dihydroartemisinin Revenue Share by Type (2015-2020)
Table 82. Global Dihydroartemisinin Sales by Application (2015-2020) (K MT)
Table 83. Global Dihydroartemisinin Sales Share by Application (2015-2020)
Table 84. Global Dihydroartemisinin Sales Forecast by Regions (2021-2025) (K MT)
Table 85. Global Dihydroartemisinin Market Share Forecast by Regions (2021-2025)
Table 86. Global Dihydroartemisinin Sales Forecast by Type (2021-2025) (K MT)
Table 87. Global Dihydroartemisinin Market Share Forecast by Type (2021-2025)
Table 88. Global Dihydroartemisinin Sales Forecast by Application (2021-2025)
Table 89. Global Dihydroartemisinin Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Dihydroartemisinin Picture
Figure 2. Global Sales Market Share of Dihydroartemisinin by Type in 2019
Figure 3. Pharmaceutical Grade Picture
Figure 4. Industrial Grade Picture
Figure 5. Dihydroartemisinin Sales Market Share by Application in 2018
Figure 6. Malaria Treatment Picture
Figure 7. Scientific Research Picture
Figure 8. Others Picture
Figure 9. Global Dihydroartemisinin Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Dihydroartemisinin Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Dihydroartemisinin Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Dihydroartemisinin Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Dihydroartemisinin Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Dihydroartemisinin Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Dihydroartemisinin Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Dihydroartemisinin Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Dihydroartemisinin Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Dihydroartemisinin Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Dihydroartemisinin Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Dihydroartemisinin Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Dihydroartemisinin Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Dihydroartemisinin Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Dihydroartemisinin Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Dihydroartemisinin Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Dihydroartemisinin Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Dihydroartemisinin Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Dihydroartemisinin Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Dihydroartemisinin Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Dihydroartemisinin Sales Market Share by Manufacturer in 2019
Figure 30. Global Dihydroartemisinin Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Dihydroartemisinin Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Dihydroartemisinin Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 35. Global Dihydroartemisinin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Dihydroartemisinin Revenue Market Share by Regions (2015-2020)
Figure 37. Global Dihydroartemisinin Revenue Market Share by Regions in 2018
Figure 38. North America Dihydroartemisinin Sales and Growth Rate (2015-2020)
Figure 39. Europe Dihydroartemisinin Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Dihydroartemisinin Sales and Growth Rate (2015-2020)
Figure 41. South America Dihydroartemisinin Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Dihydroartemisinin Sales and Growth Rate (2015-2020)
Figure 43. North America Dihydroartemisinin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Dihydroartemisinin Sales Market Share by Countries (2015-2020)
Figure 45. North America Dihydroartemisinin Sales Market Share by Countries in 2018
Figure 46. North America Dihydroartemisinin Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Dihydroartemisinin Revenue Market Share by Countries in 2018
Figure 48. United States Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 49. Canada Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Mexico Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Europe Dihydroartemisinin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Dihydroartemisinin Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Dihydroartemisinin Revenue Market Share by Countries in 2019
Figure 54. Germany Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 55. UK Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 56. France Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 57. Russia Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Italy Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Asia-Pacific Dihydroartemisinin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Dihydroartemisinin Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Dihydroartemisinin Revenue Market Share by Regions 2019
Figure 62. China Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Japan Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Korea Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 65. India Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Southeast Asia Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 67. South America Dihydroartemisinin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Dihydroartemisinin Sales Market Share by Countries in 2019
Figure 69. South America Dihydroartemisinin Revenue Market Share by Countries in 2019
Figure 70. Brazil Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 71. Argentina Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Middle East and Africa Dihydroartemisinin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Dihydroartemisinin Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Dihydroartemisinin Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Dihydroartemisinin Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 77. Egypt Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Turkey Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 79. South Africa Dihydroartemisinin Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Global Dihydroartemisinin Sales and Growth Rate (2021-2025) (K MT)
Figure 81. Global Dihydroartemisinin Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Dihydroartemisinin Market Forecast (2021-2025) (K MT)
Figure 83. Europe Sales Dihydroartemisinin Market Forecast (2021-2025) (K MT)
Figure 84. Asia-Pacific Sales Dihydroartemisinin Market Forecast (2021-2025) (K MT)
Figure 85. South America Sales Dihydroartemisinin Market Forecast (2021-2025) (K MT)
Figure 86. Middle East & Africa Sales Dihydroartemisinin Market Forecast (2021-2025) (K MT)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
アルテミシニン誘導体の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Artemisinin Derivatives market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Artemisinin Derivativ…- マラリア薬の世界市場レポート2020 A recently published report by QY Research titled Global Drugs for Malaria Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate …
- 医薬品用ニトログリセリンの世界市場レポート2020 A recently published report by QY Research titled Global Pharmaceutical-grade Nitroglycerin Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically p…
- 医薬品用塩化ナトリウムの世界市場レポート2020 Sodium chloride (NaCl) is the chemical name for salt. Sodium chloride occurs naturally as the mineral halite. Commercially, it is obtained by the solar evaporation of salt water, or by mining. It is a component of sodium chloride injections USP, and has production uses in pharmaceutical processing. …
- 医薬品グレードビタミンB3の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pharmaceutical Grade Vitamin B3 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pharmaceutica…